Page 92 - 73_03
P. 92
VOL. 73 (3), 703-746, 2007 ARE ADRENOMEDULLIN POSITIVE MODULATORS NOVEL...
for the search of MMP-2 inhibitors with interest for the treatment of
many inflammatory, malignant, and degenerative diseases.
ACKNOWLEDGMENT
This work was supported by the Spanish Ministry of Education
(SAF2005-02608). S. M.-S. thanks Ministerio de Educación y Ciencia
for a Ramón y Cajal contract. Grant to M. A. G. from Comunidad
Autónoma de Madrid is also acknowledged.
BIBLIOGRAPHY
(1) MARTÍNEZ, A.; OH, H. R.; UNSWORTH, E. J.; BREGONZIO, C.; SAAVEDRA, J. M.;
STETLER-STEVENSON, W. and CUTTITTA, F. (2004): Matrix metalloproteinase-2
cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator.
Biochem. J. 383: 1-6.
(2) MARTÍNEZ, A.; JULIAN, M.; BREGONZIO, C.; NOTARI, L.; MOODY, T. and CUTTITA,
F. (2004): Identification of vasoactive non-peptidic positive and negative
modulators of adrenomedullin using a neutralizing antibody-based screening
strategy. Endocrinology 145: 3858-3865.
(3) JOHNSON, L. L.; DYER, R. and HUPE, D. J. (1998): Matrix metalloproteinases.
Curr. Opin. Chem. Biol. 2: 466-471.
(4) PIRARD, B. and MATTER, H. (2006): Matrix metalloproteinase target family
landscape: a chemometrical approach to ligand selectivity based on protein
binding site analysis. J. Med. Chem. 49: 51-69.
(5) BABINE, R. E. and BENDER, S. L. (1997): Molecular Recognition of Protein-
Ligand Complexes: Applications to Drug Design. Chem. Rev. 97: 1359-1472.
(6) VERMA, R. P. and HANSCH, C. (2007): Matrix metalloproteinases (MMPs):
Chemical-biological functions and (Q)SARs. Bioorg. Med. Chem. 15: 2223-
2268.
(7) WHITTAKER, M.; FLOYD, C. D.; BROWN, P. and GEARING, A. J. (1999): Design and
therapeutic application of matrix metalloproteinase inhibitors. Chem. Rev.
99: 2735-2776.
(8) LOVEJOY, B.; HASSELL, A. M.; LUTHER, M. A.; WEIGL, D. and JORDAN, S. R. (1994):
Crystal structures of recombinant 19-kDa human fibroblast collagenase
complexed to itself. Biochemistry (Mosc). 33: 8207-8217.
(9) SCOZZAFAVA, A. and SUPURAN, C. T. (2000): Protease inhibitors: Synthesis
of potent bacterial collagenase and matrix metalloproteinase inhibitors
incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties. J. Med.
Chem. 43: 1858-1865.
721